Compare WVE & BXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | BXC |
|---|---|---|
| Founded | 2012 | 2004 |
| Country | United States | United States |
| Employees | N/A | 1700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Wholesale Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 744.8M | 706.5M |
| IPO Year | 2015 | 2004 |
| Metric | WVE | BXC |
|---|---|---|
| Price | $3.45 | $71.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 4 |
| Target Price | $18.06 | ★ $88.33 |
| AVG Volume (30 Days) | ★ 2.9M | 120.1K |
| Earning Date | 11-09-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.62 |
| Revenue | ★ $3,704,000.00 | N/A |
| Revenue This Year | $19.21 | $5.56 |
| Revenue Next Year | N/A | $4.54 |
| P/E Ratio | ★ N/A | $113.82 |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $3.43 | $44.78 |
| 52 Week High | $21.73 | $93.80 |
| Indicator | WVE | BXC |
|---|---|---|
| Relative Strength Index (RSI) | 25.92 | 42.34 |
| Support Level | N/A | $47.84 |
| Resistance Level | $6.33 | $81.73 |
| Average True Range (ATR) | 0.23 | 3.92 |
| MACD | -0.02 | -0.60 |
| Stochastic Oscillator | 8.56 | 14.29 |
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
BlueLinx Holdings Inc is engaged in the wholesale distribution of residential and commercial building products. Its business products are split into two categories: Structural products include items such as lumber, plywood, oriented strand board, rebar, and remesh, and Specialty products include items such as engineered wood, siding, millwork, outdoor living, specialty lumber and panels, and industrial products. The company's operations are carried out throughout the United States.